Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Inhibition of HIV entry by extracellular glucuronoxylomannan of Cryptococcus neoformans.

Yi HA, Panepinto JC, Jacobs A.

Microb Pathog. 2012 Jan;52(1):25-30. doi: 10.1016/j.micpath.2011.09.007. Epub 2011 Oct 2.

PMID:
21983597
2.

Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens.

Pirofski LA.

Trends Microbiol. 2001 Sep;9(9):445-51. Review.

PMID:
11553457
3.

Receptor-mediated recognition of Cryptococcus neoformans.

Levitz SM.

Nihon Ishinkin Gakkai Zasshi. 2002;43(3):133-6. Review.

4.

Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection.

Feldmesser M, Casadevall A.

Front Biosci. 1998 Feb 1;3:d136-51. Review.

PMID:
9445465
5.

Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model.

Devi SJ.

Vaccine. 1996 Jun;14(9):841-4. Review. Erratum in: Vaccine 1996 Sep;14(13):1298.

PMID:
8843625
6.

Glucuronoxylomannan exhibits potent immunosuppressive properties.

Monari C, Bistoni F, Vecchiarelli A.

FEMS Yeast Res. 2006 Jun;6(4):537-42. Review.

7.

[Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire].

Muyembe Tamfum JJ, Mupapa Kibadi D, Nganda L, Ngwala-Bikindu D, Kuezina T, Kela-We I, Vandepitte J.

Med Trop (Mars). 1992 Oct-Dec;52(4):435-8. Review. French.

PMID:
1494313
8.

[Cryptococcosis].

Yoshida K, Shoji H, Niki Y.

Nihon Rinsho. 2008 Dec;66(12):2350-5. Review. Japanese.

PMID:
19069104
10.

Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection.

Lederman MM, Jump R, Pilch-Cooper HA, Root M, Sieg SF.

Retrovirology. 2008 Dec 18;5:116. doi: 10.1186/1742-4690-5-116. Review.

11.

A yeast under cover: the capsule of Cryptococcus neoformans.

Bose I, Reese AJ, Ory JJ, Janbon G, Doering TL.

Eukaryot Cell. 2003 Aug;2(4):655-63. Review. No abstract available.

Supplemental Content

Support Center